WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.2% of their position (13.08K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $1.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/21/2022ACC: 0001213900-22-033752
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+13.08K
Net shares
Net buyer
$1.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
13.08K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.08K
Price / share
$0.11
Trade value
$1.50K
% of position
0.2%
6/17/2022
7.71M→7.72M
Total
Net shares
+13.08K
Net value
$1.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2022 | P · Purchase | +13.08K | $0.11 | $1.50K | 0.2% | 7.71M | 7.72M |
| Total | +13.08K | $1.50K | ||||||
Derivative Transactions0
No derivative transactions reported